Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2221 to 2223 of 2223 entries
Sorted by: Best Match Show Resources per page
Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12.

bioRxiv : the preprint server for biology

Jimenez-Guardeño JM, Ortega-Prieto AM, Moreno BM, Maguire TJA, Richardson A, Diaz-Hernandez JI, Perez JD, Zuckerman M, Playa AM, Deline CC, Malim MH, Martinez-Nunez RT.
PMID: 34401881
bioRxiv. 2021 Aug 10; doi: 10.1101/2021.06.25.449609.

The COVID-19 pandemic has accelerated the need to identify new therapeutics at pace, including through drug repurposing. We employed a Quadratic Unbounded Binary Optimization (QUBO) model, to search for compounds similar to Remdesivir (RDV), the only antiviral against SARS-CoV-2...

Cite
Jimenez-Guardeño JM, Ortega-Prieto AM, Moreno BM, et al. Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12. bioRxiv. 2021;doi: 10.1101/2021.06.25.449609.
Jimenez-Guardeño, J. M., Ortega-Prieto, A. M., Moreno, B. M., Maguire, T. J. A., Richardson, A., Diaz-Hernandez, J. I., Perez, J. D., Zuckerman, M., Playa, A. M., Deline, C. C., Malim, M. H., & Martinez-Nunez, R. T. (2021). Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.06.25.449609
Jimenez-Guardeño, Jose M, et al. "Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.06.25.449609
Jimenez-Guardeño JM, Ortega-Prieto AM, Moreno BM, Maguire TJA, Richardson A, Diaz-Hernandez JI, Perez JD, Zuckerman M, Playa AM, Deline CC, Malim MH, Martinez-Nunez RT. Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12. bioRxiv. 2021 Aug 10; doi: 10.1101/2021.06.25.449609. PMID: 34401881; PMCID: PMC8366797.
Copy Download .nbib Format: NLM
Veterans Administration support for medical research: opinions of the endangered species of physician-scientists.

Zucker S, Crabbe JC, Cooper G, Finkelman F, Largman C, McCarley RW, Rice L, Rubin J, Richardson B, Seil F, Snider GL, Vandenbark AA.
UIID-AD: 325
2004;18:1481-1486. doi: 10.1096/fj.04-1573lfe.

Over the past three decades the Veterans Affairs (VA) Research program has evolved into a powerful, peer-reviewed funding mechanism for basic and translational research that has resulted in numerous important contributions to medical science and improvements in patient care....

Cite
Zucker S, Crabbe JC, Cooper G, et al. Veterans Administration support for medical research: opinions of the endangered species of physician-scientists. 2004;18:1481-1486doi: 10.1096/fj.04-1573lfe.
Zucker, S., Crabbe, J. C., Cooper, G., Finkelman, F., Largman, C., McCarley, R. W., Rice, L., Rubin, J., Richardson, B., Seil, F., Snider, G. L., & Vandenbark, A. A. (2004). Veterans Administration support for medical research: opinions of the endangered species of physician-scientists. 181481-1486. https://doi.org/10.1096/fj.04-1573lfe
Zucker, S, et al. "Veterans Administration support for medical research: opinions of the endangered species of physician-scientists." vol. 18 (2004): 1481-1486. doi: https://doi.org/10.1096/fj.04-1573lfe
Zucker S, Crabbe JC, Cooper G, Finkelman F, Largman C, McCarley RW, Rice L, Rubin J, Richardson B, Seil F, Snider GL, Vandenbark AA. Veterans Administration support for medical research: opinions of the endangered species of physician-scientists. 2004;18:1481-1486. doi: 10.1096/fj.04-1573lfe. UIID-AD: 325.
Copy Download .nbib Format: NLM
The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged students.

Dalley B, Podawiltz A, Castro R, Fallon K, Kott M, Rabek J, Richardson J, Thomson W, Ferry P, Mabry B, Hermesmeyer P, Smith Q.
UIID-AD: 2982
2009;84:1373-82. doi: 10.1097/ACM.0b013e3181b6c76b.

In 2003, Texas initiated an experiment to address enrollment disparities in its medical schools. With bipartisan support from key Texas legislators, funding was allocated in 2002 to establish the Joint Admission Medical Program (JAMP). Texas' then eight medical schools...

Cite
Dalley B, Podawiltz A, Castro R, et al. The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged students. 2009;84:1373-82doi: 10.1097/ACM.0b013e3181b6c76b.
Dalley, B., Podawiltz, A., Castro, R., Fallon, K., Kott, M., Rabek, J., Richardson, J., Thomson, W., Ferry, P., Mabry, B., Hermesmeyer, P., & Smith, Q. (2009). The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged students. 841373-82. https://doi.org/10.1097/ACM.0b013e3181b6c76b
Dalley, B, et al. "The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged students." vol. 84 (2009): 1373-82. doi: https://doi.org/10.1097/ACM.0b013e3181b6c76b
Dalley B, Podawiltz A, Castro R, Fallon K, Kott M, Rabek J, Richardson J, Thomson W, Ferry P, Mabry B, Hermesmeyer P, Smith Q. The Joint Admission Medical Program: a statewide approach to expanding medical education and career opportunities for disadvantaged students. 2009;84:1373-82. doi: 10.1097/ACM.0b013e3181b6c76b. UIID-AD: 2982.
Copy Download .nbib Format: NLM
Showing 2221 to 2223 of 2223 entries